Literature DB >> 12027875

Effects of high doses of glucocorticoids on free amino acids, ribosomes and protein turnover in human muscle.

E Löfberg1, A Gutierrez, J Wernerman, B Anderstam, W E Mitch, S R Price, J Bergström, A Alvestrand.   

Abstract

BACKGROUND: Treatment with glucocorticosteroids causes a negative nitrogen balance, but the kinetic mechanisms responsible for this catabolic effect are controversial. We investigated the effects of 60 mg day(-1) prednisolone on protein synthesis and degradation in human skeletal muscle.
MATERIALS AND METHODS: Healthy adults (n = 9) were studied in the postabsorptive state, before and after 3 days of prednisolone treatment. The L-[ring 2,6(-3)H(5)]-phenylalanine tracer technique, concentration and size distribution of the ribosomes, mRNA content of the ubiquitin-proteasome pathway components in muscle, phenylalanine flux across the leg, and the free amino acid concentrations in skeletal muscle were used to study muscle protein metabolism.
RESULTS: The concentrations of most amino acids in arterial blood increased after prednisolone. There were also increased effluxes of phenylalanine, asparagine, arginine, alanine, methionine and isoleucine from the leg. The rate of protein degradation, as measured by the appearance rate (Ra) of phenylalanine, increased by 67% (P = 0.023) which, together with a doubling of the net release of phenylalanine from the leg (P = 0.007), indicated accelerated protein degradation. The pathway was not identified but there was no significant increase in mRNAs' encoding components of the ubiquitin-proteasome pathway. There was a 6% reduction in polyribosomes (P = 0.007), suggesting a decrease in the capacity for protein synthesis, although there was no measured decrease in the rate of protein synthesis.
CONCLUSIONS: These findings indicate that high doses of prednisolone lead to a sharp increase in net protein catabolism, which depends more on enhanced protein breakdown, and an uncertain effect on protein synthesis. The mechanisms stimulating proteolysis and the pathway stimulated to increase muscle protein degradation should be explored.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027875     DOI: 10.1046/j.1365-2362.2002.00993.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  39 in total

1.  Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo.

Authors:  Gunter Fingerle-Rowson; Peter Koch; Rachel Bikoff; Xinchun Lin; Christine N Metz; Firdaus S Dhabhar; Andreas Meinhardt; Richard Bucala
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

2.  Taking KLF9 to "Cort" for crimes against metabolism.

Authors:  David R Sweet; Liyan Fan; Mukesh K Jain
Journal:  J Clin Invest       Date:  2019-04-29       Impact factor: 14.808

3.  Role of IGF-I and the TNFα/NF-κB pathway in the induction of muscle atrogenes by acute inflammation.

Authors:  O Schakman; M Dehoux; S Bouchuari; S Delaere; P Lause; N Decroly; S E Shoelson; J-P Thissen
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-06-26       Impact factor: 4.310

Review 4.  Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases.

Authors:  Rowan S Hardy; Karim Raza; Mark S Cooper
Journal:  Nat Rev Rheumatol       Date:  2020-02-07       Impact factor: 20.543

Review 5.  Skeletal muscle atrophy: disease-induced mechanisms may mask disuse atrophy.

Authors:  C J Malavaki; G K Sakkas; G I Mitrou; A Kalyva; I Stefanidis; K H Myburgh; C Karatzaferi
Journal:  J Muscle Res Cell Motil       Date:  2016-01-04       Impact factor: 2.698

6.  Effect of antenatal betamethasone on maternal and fetal amino acid concentration.

Authors:  Anna Maria Marconi; Valentina Mariotti; Cecilia Teng; Stefania Ronzoni; Barbara D'Amato; Alberto Morabito; Frederick C Battaglia
Journal:  Am J Obstet Gynecol       Date:  2009-12-21       Impact factor: 8.661

7.  Role of Akt/GSK-3beta/beta-catenin transduction pathway in the muscle anti-atrophy action of insulin-like growth factor-I in glucocorticoid-treated rats.

Authors:  O Schakman; S Kalista; L Bertrand; P Lause; J Verniers; J M Ketelslegers; J P Thissen
Journal:  Endocrinology       Date:  2008-05-08       Impact factor: 4.736

8.  Effects of dexamethasone on the expression of beta(1)-, beta (2)- and beta (3)-adrenoceptor mRNAs in skeletal and left ventricle muscles in rats.

Authors:  Fuuun Kawano; Jun Tanihata; Shogo Sato; Sachiko Nomura; Akira Shiraishi; Kaoru Tachiyashiki; Kazuhiko Imaizumi
Journal:  J Physiol Sci       Date:  2009-07-08       Impact factor: 2.781

9.  Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.

Authors:  Brett D Dufour; Jodi L McBride
Journal:  Neurobiol Dis       Date:  2018-10-05       Impact factor: 5.996

10.  The effect of high glucocorticoid administration and food restriction on rodent skeletal muscle mitochondrial function and protein metabolism.

Authors:  Y Nancy You; Kevin R Short; Marion Jourdan; Katherine A Klaus; Stephane Walrand; K Sreekumaran Nair
Journal:  PLoS One       Date:  2009-04-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.